Review: taking Risperidone and Intuniv together


Summary

Drug interactions are reported among people who take Risperidone and Intuniv together. This review analyzes the effectiveness and drug interactions between Risperidone and Intuniv. It is created by eHealthMe based on reports of 241 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Risperidone and Intuniv >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Risperidone

Risperidone has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperidone 16,981 users)

Intuniv

Intuniv has active ingredients of guanfacine hydrochloride. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Intuniv 1,024 users)

On Aug, 30, 2016

241 people who take Risperidone, Intuniv are studied.


Number of reports submitted per year:

Risperidone and Intuniv drug interactions.

Drug effectiveness over time:

Risperidone:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 50.0% - (2 of 4 people)
  • 1 - 2 years: 20.0% - (1 of 5 people)
  • 2 - 5 years: 27.0% - (3 of 11 people)
  • 5 - 10 years: 75.0% - (3 of 4 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Intuniv:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 3 people)
  • 1 - 2 years: 0.0% - (0 of 7 people)
  • 2 - 5 years: 12.0% - (1 of 8 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Risperidone:
  • female: 20.0% - (1 of 5 people)
  • male: 34.0% - (8 of 23 people)
Intuniv:
  • female: 20.0% - (1 of 5 people)
  • male: 14.0% - (3 of 21 people)

Drug effectiveness by age:

Risperidone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 16.0% - (2 of 12 people)
  • 10-19: 35.0% - (5 of 14 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Intuniv:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 7.0% - (1 of 13 people)
  • 10-19: 18.0% - (2 of 11 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • accidental exposure
  • malaise
  • physical assault
  • convulsion
  • excessive eye blinking
  • eye pain
  • muscle spasms
  • muscle twitching
  • blindness
  • disturbance in social behaviour
1 - 6 months:
  • homicidal ideation
  • hallucination, visual
  • aggression aggravated
  • convulsion
  • excessive eye blinking
  • eye pain
  • hyperglycaemia
  • hypoglycaemia
  • lipids increased
  • muscle spasms
6 - 12 months:
  • aggression
  • agitation
  • tardive dyskinesia
  • convulsion
  • extrapyramidal disorder
  • foaming at mouth
  • anticonvulsant drug level below therapeutic
  • autism
  • bipolar disorder
  • blood thyroid stimulating hormone decreased
1 - 2 years:
  • suicidal ideation
  • aggression
  • blood prolactin increased
  • emotional disorder
  • fear
  • glucose tolerance impaired
  • gynaecomastia
  • hallucination, visual
  • homicidal ideation
  • migraine
2 - 5 years:
  • breast pain
  • breast tenderness
  • emotional disorder
  • glucose tolerance impaired
  • aggression
  • depression
  • gynaecomastia
  • obesity
  • acne
  • blood triglycerides increased
5 - 10 years:
  • tardive dyskinesia
  • cough
  • delayed puberty
  • dizziness aggravated
  • sleepiness - during the day
  • weight gain - unintentional
not specified:
  • aggression
  • abnormal behaviour
  • weight increased
  • convulsion
  • drug ineffective
  • somnolence
  • tic
  • dyskinesia
  • suicidal ideation
  • extrapyramidal disorder

Most common drug interactions by gender *:

female:
  • aggression
  • convulsion
  • drug ineffective
  • weight increased
  • self injurious behaviour
  • hallucination, visual
  • homicidal ideation
  • oedema peripheral
  • arthralgia
  • chest pain
male:
  • aggression
  • abnormal behaviour
  • convulsion
  • weight increased
  • somnolence
  • gynaecomastia
  • drug ineffective
  • obesity
  • tardive dyskinesia
  • suicidal ideation

Most common drug interactions by age *:

0-1:
  • aggression
  • convulsion
  • agitation
  • depressed level of consciousness
  • fatigue
  • foaming at mouth
  • pancreatitis acute
  • somnolence
  • tardive dyskinesia
  • weight gain
2-9:
  • convulsion
  • eye pain
  • drug ineffective
  • excessive eye blinking
  • muscle spasms
  • muscle twitching
  • suicidal ideation
  • abnormal behaviour
  • aggression
  • drug administration error
10-19:
  • aggression
  • abnormal behaviour
  • weight increased
  • tic
  • convulsion
  • extrapyramidal disorder
  • dyskinesia
  • drug ineffective
  • streptococcal infection
  • therapeutic response increased
20-29:
  • grand mal convulsion
  • aggression
  • agonal rhythm
  • blood glucose increased
  • blood pressure increased
  • bradycardia
  • constipation
  • cough
  • decreased activity
  • depression
30-39:
  • blood cholesterol increased
  • borderline personality disorder
  • convulsion
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • epilepsy
  • feeling abnormal
  • glucose tolerance impaired
  • headache
  • hyperlipidaemia
40-49:
  • visual impairment
  • atrophy
  • burning sensation
  • claustrophobia
  • constipation
  • convulsion
  • crying
  • depression
  • drug ineffective
  • enuresis
50-59:
  • abdominal distension
  • arthralgia
  • bronchitis
  • chronic obstructive pulmonary disease
  • diabetes mellitus inadequate control
  • diarrhoea
  • folliculitis
  • gallbladder disorder
  • hepatic enzyme increased
  • hypertension
60+:
  • cardiac failure congestive
  • cerebrovascular disorder
  • chronic obstructive pulmonary disease
  • concomitant disease progression
  • convulsion
  • drug level decreased
  • ear infection
  • hypoglycaemia
  • hyponatraemia
  • pneumonia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Risperidone and Intuniv?

Can you answer these questions?

More questions for: Risperidone, Intuniv

You may be interested in these reviews

More reviews for: Risperidone, Intuniv

On eHealthMe, Risperidone (risperidone) is often used to treat schizophrenia. Intuniv (guanfacine hydrochloride) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.